Clinical Oncology Next-Generation Sequencing Market Overview
A report on the Clinical Oncology Next-Generation Sequencing market was released by MMR. The research combines primary and secondary data, and subject matter experts have examined it from both a local and global standpoint. An important tool for investors, the study offers a thorough analysis of the market’s size and share in every area and category.
Explore additional details by clicking the link provided@ https://www.maximizemarketresearch.com/request-sample/100383
Clinical Oncology Next-Generation Sequencing Market Dynamics:
The United States saw 1.7 million new instances of cancer and 0.6 million cancer-related deaths in 2019, according to the American Cancer Society. The four most common cancers worldwide are female breast cancer, bladder cancer, prostate cancer, and lung cancer, together making up 43% of all new cancer cases. Thus, it is anticipated that the rise in cancer incidence rates worldwide would raise demand for next-generation sequencing in clinical oncology.
Clinical Oncology Next-Generation Sequencing Market Report Scope and Research Methodology:
The report provides an in-depth analysis of the Clinical Oncology Next-Generation Sequencing market at the global, regional, and country levels. It provides a comprehensive analysis of the competitive landscape of the Clinical Oncology Next-Generation Sequencing industry, including the business strategies adopted by the key players. The report includes a list of the Clinical Oncology Next-Generation Sequencing key competitors, along with information on their revenue, production capacity, sales, and global presence. SWOT analysis was used to identify the strengths and weaknesses of the key players in the Clinical Oncology Next-Generation Sequencing industry. Detailed information on the Clinical Oncology Next-Generation Sequencing market dynamics, including drivers, restraints, opportunities, and challenges, is also provided in the report.
The bottom-up approach was used to estimate the global and regional Clinical Oncology Next-Generation Sequencing market size. Both primary and secondary research methods were used to gather data on market size, market share, regional insights, market dynamics, the performance of key players, and historical data of the industry. The report also includes a detailed value chain analysis, which helps to understand the manufacturing process of Clinical Oncology Next-Generation Sequencing, with information on raw materials, customers, and distributors. It also includes Porter’s and PESTLE analysis, as well as market attractiveness, which helps to understand the Clinical Oncology Next-Generation Sequencing market at the macro and micro levels.
Clinical Oncology Next-Generation Sequencing Market Regional Insights
Geographically, the report is segmented into several key countries, with market size, growth rate, import and export of Clinical Oncology Next-Generation Sequencing market in these countries, which covering North America – U.S., Canada, Mexico, Europe – UK, Germany, France, Spain, Italy, Rest of Europe, Asia Pacific – China, India, Japan, Australia, South Korea, ASEAN Countries, Rest of APAC, South America – Brazil, and Middle East and Africa.
To know about the Research Methodology:- Request Free Sample Report
Clinical Oncology Next-Generation Sequencing Market Segmentation:
by Technology
• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing Centrifuges
by Workflow
• Pre Sequencing
• Sequencing
• Data Analysis
by Application
• Screening
• Companion Diagnostics
• Other Diagnostics
by End-User
• Hospitals
• Clinics
• Laboratories
With a sales share of more than 72% in 2020, the targeted sequencing and resequencing segment saw tremendous growth based on technology. The cost, time, and amount of data analysed during the sequencing of tumour samples are often reduced by targeted cancer sequencing panels. Furthermore, the therapeutic efficacy of targeted panels is enhanced by their capacity to detect malignant tumours. A 2020 JCO Precision Oncology research found that 64 percent of cancer cases can be treated clinically with NGS panels.
Sequencing accounted for over 54% of overall revenue, making it the most profitable process category according to process. One of the most important stages of the workflow, sequencing calls for the usage of specialised platforms. The growth of the segment is further supported by an increase in the quantity of cancer sequencing programmes. The primary drivers of the pre-sequencing portion are the attempts of major stakeholders to lower the cost of NGS library planning. It is anticipated that NGS data analysis would become more common. The creation of advanced analytical tools by prominent industry players is driving the growth of this area. More than 2,600 tumour samples from 38 distinct cancer types were sequenced by the Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium.
Clinical Oncology Next-Generation Sequencing Market Key Players:
• Illumina, Inc.
• QIAGEN
• Thermo Fisher Scientific, Inc.
• F. Hoffman-La Roche Technologies
• Agilent Technologies
• Myriad Genetics
• Foundation Medicine
• Pacific Bioscience
• Oxford Nanopore Technologies Ltd.
• Beijing Genomics Institute (BGI)
• Perkin Elmer, Inc.
• Paradigm Diagnostics
• Caris Life Sciences
• Partek, Inc.
• Eurofins Scientific S.E.
• Bio Rad Laboratories, Inc.
• Other Key Players
Key Questions answered in the Clinical Oncology Next-Generation Sequencing Market Report are:
- What is the expected Clinical Oncology Next-Generation Sequencing market size by 2030?
- What will be the CAGR of the Clinical Oncology Next-Generation Sequencing market during the forecast period?
- Which segment held the largest share in the Clinical Oncology Next-Generation Sequencing market?
- How is the competitive scenario of the Clinical Oncology Next-Generation Sequencing market?
- Which are the key factors driving the Clinical Oncology Next-Generation Sequencing market growth?
- What are the factors restraining the Clinical Oncology Next-Generation Sequencing market growth?
- Which region holds the maximum share in the Clinical Oncology Next-Generation Sequencing market?
- Who are the key players in the Clinical Oncology Next-Generation Sequencing market?
Explore additional details by clicking the link provided@ https://www.maximizemarketresearch.com/request-sample/100383
Key Offerings:
- A detailed Market Overview
- Market Share
- Market Size
- Market Forecast by Revenue
- Market Dynamics- Growth drivers, Restraints, Investment Opportunities, and key trends
- Market Segmentation- A detailed analysis of each segment and their segments
- Competitive Landscape – Leading key players and other prominent key players.
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
+91 96071 95908, +91 9607365656
Related Reports:
Paraben Market https://www.maximizemarketresearch.com/market-report/paraben-market-overview-market/199865/
